Arvinas Inc

ARVN NASDAQ Healthcare & Biotech United States US04335A1051
7.60 $
2.01 %

Arvinas Inc is a player in the biotechnology sector, developing drugs using targeted protein degradation technology to treat diseases such as cancer and neurodegenerative disorders.